These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22282101

  • 21. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. The Transdermal Estradiol Patch Study Group.
    Gordon SF, Thompson KA, Ruoff GE, Imig JR, Lane PJ, Schwenker CE.
    Int J Fertil Menopausal Stud; 1995; 40(3):126-34. PubMed ID: 7663539
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
    Speroff L, Haney AF, Gilbert RD, Ellman H, Estradiol Acetate Investigator Group.
    Menopause; 2006; 13(3):442-50. PubMed ID: 16735941
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.
    Aguirre W, Chedraui P, Mendoza J, Ruilova I.
    Gynecol Endocrinol; 2010 May; 26(5):333-7. PubMed ID: 20050764
    [Abstract] [Full Text] [Related]

  • 26. An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.
    Gerlinger C, Gude K, Hiemeyer F, Schmelter T, Schäfers M.
    Menopause; 2012 Jul; 19(7):799-803. PubMed ID: 22228322
    [Abstract] [Full Text] [Related]

  • 27. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
    Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA.
    Menopause; 2006 Jul; 13(3):411-22. PubMed ID: 16735938
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH, Beijers-De Bie L, Vihtamaki T, Tuimala R, Siseles N, Magaril C, The HS, Houben PW, Murga M, Spielmann D, De Villiers TJ.
    Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.
    Rozenbaum H, Chevallier O, Moyal M, Durand G, Perineau M, This P, Aerodiol study group.
    Climacteric; 2002 Sep 20; 5(3):249-58. PubMed ID: 12419083
    [Abstract] [Full Text] [Related]

  • 36. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
    Adler G, Young D, Galant R, Quinn L, Witchger MS, Maki KC.
    Gynecol Obstet Invest; 2005 Sep 20; 59(4):212-9. PubMed ID: 15753617
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA, Reape KZ, Wininger S, Hait H.
    Fertil Steril; 2008 Oct 20; 90(4):1132-8. PubMed ID: 18053998
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
    Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D.
    Obstet Gynecol; 2005 Apr 20; 105(4):779-87. PubMed ID: 15802405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.